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Bacteria colonizing the human intestinal tract exhibit a high phylogenetic diversity that
reflects their immense metabolic potentials. The catalytic activity of gut microbes has
an important impact on gastrointestinal (GI) functions and host health. The microbial
conversion of carbohydrates and other food components leads to the formation of a large
number of compounds that affect the host metabolome and have beneficial or adverse
effects on human health. Metabolomics is a metabolic-biology system approach focused
on the metabolic responses understanding of living systems to physio-pathological
stimuli by using multivariate statistical data on human body fluids obtained by different
instrumental techniques. A metabolomic approach based on an analytical platform could
be able to separate, detect, characterize and quantify a wide range of metabolites
and its metabolic pathways. This approach has been recently applied to study the
metabolic changes triggered in the gut microbiota by specific diet components and diet
variations, specific diseases, probiotic and synbiotic food intake. This review describes
the metabolomic data obtained by analyzing human fluids by using different techniques
and particularly Gas Chromatography Mass Spectrometry Solid-phase Micro Extraction
(GC-MS/SPME), Proton Nuclear Magnetic Resonance (1H-NMR) Spectroscopy and Fourier
Transform Infrared (FTIR) Spectroscopy. This instrumental approach has a good potential
in the identification and detection of specific food intake and diseases biomarkers.
Keywords: metabolites, instrumental methods, gut microbiota, diet, biomarkers
INTRODUCTION
The human intestine is home of some 100 trillion of microorgan-
isms of at least hundreds species. The density of bacterial cells in
the colon has been estimated at 1011–1012 per ml, which makes
it one of the most densely populated known microbial habitats
(Eckburg et al., 2005; Ley et al., 2006; Vitali et al., 2010). This
microbial ecosystem serves numerous important functions for
the human host, including protection against pathogens, nutrient
processing, stimulation of angiogenesis, modulation of intesti-
nal immune response, and regulation of host fat storage (Palmer
et al., 2007). The composition of the adult gastrointestinal (GI)
microbiota has been intensely studied, using both classical micro-
biology cultivation and, more recently, culture-independent,
small subunit (SSU) ribosomal DNA (rDNA) sequence-based
methods (Palmer et al., 2006, 2007; Huse et al., 2008; Vitali et al.,
2010).
The prevention and treatment of gut-related diseases will
strongly depend on understanding the mechanisms involved in
the complex processes of digestion. However, the interactions
between the diet, microbiota and host are largely unknown
(Quigley, 2011; Del Chierico et al., 2012; Nicholson et al., 2012;
Payne et al., 2012).
This review is addressed to evaluate the potential of differ-
ent analytical approaches to identify and detect the molecules
present in body fluids, such as blood, urine, feces, which can be
considered originated by food digestion, diet/gut microbiota, and
host/microbiota interactions as well as disease markers.
DIET EFFECT ON HUMAN GUTMETABOLOME
Foods contain thousands of compounds which, upon digestion
and metabolism, give rise to complex physiological reactions
and possible changes in the intestinal microbiota profile result-
ing in a plethora of metabolites present in body fluids such
as blood, urine, feces, and saliva. The number and diversity
of chemical compounds in foods is amazing. It has been esti-
mated that an omnivore diet exposes humans to more than
15,000 components, 8000 out of which are non-nutrients such
as dietary fiber, antioxidants, prebiotics, and probiotics (Wishart,
2008).
An individual food system such as milk contains more than
200 different oligosaccharides, and the edible plants metabolome
consist of more than 10,000 detectable compounds and 800 non-
nutrient phytochemicals (Wishart, 2008). These molecules and
their accumulation in body fluids, and in particular in urine, can
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be regarded as a repository of metabolites in which any nutrient
or non-nutrient that is not needed or present in excess is found.
Several food-specific biomarkers, e.g., related to wine, black tea,
coffee, fruit, and vegetables, have been identified in urine and
blood samples (Spencer et al., 2008; Wishart, 2008). Other com-
pounds occurring in different body fluids, namely blood, can
be regarded as biomarkers of physiological response to foods.
In particular, they are products of lipid peroxidation such as
8-isoprostaglandin F2alpha, and/or oxidative stress markers such
as malonaldehyde or glutathione.
Some of the diet components have a potentially direct quan-
titative and qualitative impact on the microbial species charac-
terizing the gut microbiota. Their metabolic output can harbor
physiologically active compounds for the human host which in
turn provides a stable environment for proliferation. On the
other hand the host has evolved and can use bacterial fer-
mentation products as an energy source for the epithelial cells.
Some of the fermentation products, e.g., short chain fatty acids
(SCFAs), can positively affect the biochemical and physiological
processes at colon level and support some important biolog-
ical functions (Wong et al., 2006). However, the influence of
the bacterial population composition on inter-individual differ-
ences in metabolites production and colon health status is poorly
understood, except for the well-known relationships between
some specific metabolites and metabolic diseases (Le Gall et al.,
2011).
Metabolic profiling has a wide potential for understanding the
complex interactions between components of the gut microbiota,
and elucidate the cause/effects relationships associated with spe-
cific nutritional choices and the related shifts in the microbiota
composition.
Particularly challenging is the metabolic signatures identifi-
cation of many phenotypes and their linkage with nutritional
choices. In fact, the whole set of metabolites which can be detected
in body fluids, and which characterizes the metabolic phenotype,
named “metabotype” (Waldram et al., 2009), of an individual, is
affected by various intrinsic and extrinsic factors including envi-
ronment, drugs, diets, lifestyle, and genetics. It should be also
considered that the content of non-nutrients in diets is higher
than that of nutrients. Such non-nutrients can exert a signif-
icant effect on metabolomic profiles thus resulting in several
compounds that can be used as biomarkers to trace the food
origin.
HOST-MICROBIOMEMETABOLIC INTERACTIONS AND
CELL-CELL COMMUNICATION
Mammalian–microbial symbiosis can play a role in the eti-
ology and development of several diseases, e.g., insulin resis-
tance, Crohn’s disease (Marchesi et al., 2007; Kinross et al.,
2011), irritable bowel syndrome (IBS) (Martin et al., 2006;
Sartor, 2008), food allergies, gastritis and peptic ulcers, obe-
sity, cardiovascular disease, and GI cancers (Martin et al., 2011).
Activities of gut microbiota can be highly specific, and it has
been reported that the establishment of Bifidobacteria is impor-
tant for the development of the immune system and manage-
ment of gut functions (Ouwehand, 2007). As the microbiome
strongly interacts with the host to determine the metabotype,
which influences outcomes of drug interventions, the knowl-
edge of these interactions can provide personalized healthcare
solutions (Martin et al., 2011). Also the diet has a key role in
the gut microbiota modulation and shaping and, as a conse-
quence, the different foods or their ingredients play a crucial role
in the microbes selection and in a metabolic signaling network
construction.
The host and its gut microbiota coproduce a large array of
small molecules during the conversion of food and xenobiotics
(compounds of non-host origin that enter the gut with the diet or
are produced by microbiota), many of which play critical roles in
shuttling information between host cells and the host’s microbial
symbionts. This chemical dialog includes signaling via lowmolec-
ular weight metabolites, peptides, and proteins or may take place
indirectly through immune-mediated pathways (Nicholson et al.,
2012). The metabolites production by microbes may influence
host health status and their detection in different body fluids can
be considered as dysbiosis or disease biomarkers (Holmes et al.,
2011; Nicholson et al., 2012) (Figure 1).
Different regions of the human GI tract vary in terms of com-
position of the indigenous microbiota (Gordon, 2012). For each
compartment of the GI tract, a chemical dialog exists among dif-
ferent microbial species, e.g., direct substrate provision in the
microbial food web, quorum sensing, contact-dependent signal-
ing, and potentially gastro-transmitters (Ryan et al., 2009) as well
as between microbial symbionts and host cells (Li et al., 2008).
Metabolites are the products and by-products of the many
intricate biosynthetic and catabolic pathways existing in all liv-
ing systems. Biological systems that exist at steady state maintain
approximately constant concentrations of metabolic intermedi-
ates (Martin et al., 2011).
Fecal extracts are the most common material which can help
to decipher the complex metabolic interplay between mammals
and their intestinal ecosystems, and metabolic profiles-related to
SCFAs, amino acids, organic acids, nucleosides and nucleotides,
polyamines, phenolic compounds, bile acids, and lipid compo-
nents can yield information on a range of gut diseases (Martin
et al., 2011).
As described by Grider and Piland (2007), SCFAs stimu-
late intestinal transit, and at physiological concentrations they
induce an 8–10-fold increase in serotonin release in an in vitro
colonic mucosal system. Moreover, Musso et al. (2011) showed
that SCFAs are clearly one of the most important gut microbiota
products and affect a range of host processes including energy uti-
lization, host-microbe signaling, and control of colonic pH with
consequent effects on microbiota composition, gut motility, and
epithelial cells proliferation.
The monitoring of the fecal metabolome also may unravel
diagnostic information for inflammatory bowel diseases
(IBDs), including Crohn’s disease and ulcerative colitis (UC),
Hirschsprung’s disease, celiac disease, allergy etc (Martin et al.,
2011). Metabolomics hasmany potential applications. It supports
functional genomics studies, systems biology, pharmacology,
toxicology, and nutrigenomics. An approach called discovery
metabolite profiling (DMP) is used to analyze all metabolites
generated by a particular enzyme, providing a link between
proteome and metabolome.
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FIGURE 1 | Schematic representation of diet, microbes, and host
interaction at gut level. The chemical dialogue via low molecular weight
metabolites, peptides, and proteins between cell-cell and host-microbes
leads to the metabolite production in different body fluids which could be
considered as disease biomarkers.
ANALYTICAL TECHNIQUES TO DETECT METABOLITES
Metabonomics represents a well-recognized metabolic system
approach that involves the study of multivariate metabolic
responses of complex cellular organisms to different stimuli
(Nicholson et al., 1999).
Ideally, it could be based on this sequence: samples col-
lection (e.g., urine, blood, or some other body fluids), scan-
ning them in a machine and finding a profile of tens or
hundreds of chemicals that can predict whether an indi-
vidual is on the road to a disease, or likely to experience
side-effects from a particular drug (Pearson, 2007). However,
this vision presents some drawbacks. The first complication
is that one person’s profile of metabolites is likely to be
dramatically different from another’s, and each may fluctu-
ate markedly depending on different aspects, for example the
lifestyle, the diseases, the diet, the nutrition etc (Pearson,
2007).
The detection and identification of hundreds metabolites can
offer deep insights on the influence of lifestyle and dietary fac-
tors in relation to specific diseases. The recent rapid development
of a range of analytical platforms, including gas chromatog-
raphy (GC), liquid chromatography (LC), high pressure LC
(HPLC), ultra pressure LC (UPLC) coupled to mass spec-
trometry (MS), capillary electrophoresis (CE) coupled to MS,
Fourier Transform Infrared (FTIR) spectroscopy, and nuclear
magnetic resonance (NMR) [e.g., proton (1H)-NMR] spec-
troscopy, can enable to separate, detect, characterize, and quan-
tify such metabolites and related metabolic pathways (Zhang
et al., 2011). Metabolomics focuses on the complex interac-
tions of system components and highlights the whole system
rather than the individual parts, providing a distinct perspec-
tive on cellular homeostasis (Liu et al., 2010). Even if nowa-
days NMR, GC-MS, LC-MS are the prevalent techniques used,
none of them is a perfect technique that can meet the require-
ments of metabolomics for measuring all metabolites. MS-based
metabolomics offers high selectivity and sensitivity for the identi-
fication and quantification of metabolites, and its combination
with advanced and high-throughput separation techniques can
reduce the complexity of metabolite separation (Zhang et al.,
2011) (Table 1).
NMR-based metabolomics is able to provide a “holistic view”
of the metabolites under certain conditions, and thus is well-
suited and advantageous for metabolomic studies (Wu et al.,
2010). In particular, it is becoming a useful tool in the study of
body fluids and for a non-invasive detection of metabolites and
into diagnosis of the diet effects on gut microbiota or significant
public health problems (Martin et al., 2012).
Usually, the measurement of the gut microbial metabolism
is confined to fecal samples, which is typically limited
because of the elevated colonic absorption of bacterial
metabolites. The Proton Nuclear Magnetic Resonance (1H-
NMR) monitoring of the human fecal metabolome also
may unravel diagnostic information for IBD including
UC (Marchesi et al., 2007). Saric et al. (2008) evaluated
the similarity and dissimilarity across different mammals
namely humans, mice, and rats by using 1H-NMR analy-
sis. The authors reported how human fecal extracts showed
greater inter-individual variation than in rodents, reflecting
the natural genetic and environmental diversity in human
population.
A major source of intestinal metabolites is both host and
microbial processing of dietary nutrients. As reported by Martin
et al. (2010) the 1H-NMR analysis of feces revealed that the
supplementation with probiotics significantly affects the host
microbiota interaction. Probiotic supplementation of “human-
ized” mice, inoculated with a model of human baby microbiota,
was associated with metabolic changes in the protein metabolism
of Lactobacillus paracasei in particular with specific aminoacidic
pattern.
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Table 1 | Common analytical techniques used in metabolomics.
Analytical Advantages Disadvantages Comments
method
NMR • Rapid analysis • Low sensitivity • Chemical consideration: gives detailed strucutural
information, particularly using 2-D-NMR of isolated
metabolites
• High resolution • Convoluted spectra • Chemical bias: these methods have little chemical
bias and can be used directly on the sample
• No derivatization method • More than one peak per
component
• Speed: few minutes to hours. Depends on the
strength of the magnet, sensitivity can be
improved by magic angle spinning
• Non-destructive • Libraries of limited use due to
complex matrix
GC-MS • Sensitive • Slow • Chemical consideration: on its own will not
generally lead to metabolite identification.
However, coupled with MS and NMR is very
powerful for analyte identification
• Robust • Often requires derivaization • Chemical bias: solvent extraction bias: non-polar
vs. polar analytes. Need for chemical derivatization
• Large linear range • Many analytes thermally-
unstable or too large for analysis
• Speed: very useful for separation, but typically take
10–30min
• Large commercial and public
libraries
LC-MS • No derivatization required
(usually)
• Slow • Chemical consideration: on its own will not
generally lead to metabolite identification.
However, coupled with MS and NMR is very
powerful for analyte identification
• Many modes of separation
available
• Limited commercial libraries • Chemical bias: solvent bias means it is usually
more applicable to polar compounds
• Speed: very useful for separation, but typically take
10–30min
• Large sample capacity
FT-IR • Rapid analysis • Extremely convoluted spectra • Chemical consideration: provide limited structural
information, but useful for identification of
functional groups
• Complete fingerprint of sample
chemical composition
• More than one peak per
component
• Chemical bias: these methods have little chemical
bias and can be used directly on the sample
• Metabolite identification nearly
impossible
• Speed: 10–60 s
• No derivatization needed • Requires samples drying
Dumas et al. (2006) have recently applied 1H-NMR technique
to characterize the intergenome interactions in mice with syn-
biotic gut microbiota as well as to monitor the gut-microbial
metabolite variation in rats and to study the intricate relation-
ships between gut microbiota and host co-metabotype associated
with dietary-induced changes. Ndagijimana et al. (2009) studied,
by means of the 1H-NMR analysis of healthy human subjects
faeces, the effect of the supplementation with a synbiotic food
based on Lactobacillus acidophilus, Bifidobactrium longum, and
Fructooligosaccharides. These authors reported that the num-
ber and the extent of metabolites in faecal slurries were strongly
affected by the synbiotic food consumption and gave rise to
characteristic metabolic signatures. Reproducibility of 1H-NMR
metabolic profiles generated from water and methanol extracts
from human stools were assessed by Jacobs et al. (2008). On the
other hand 1H-NMR is one of the preferred platforms also for
urine and plasma analysis (Ala-Korpela, 2008). The first pub-
lished study, in which a metabolomics approach on urine was
described, used the 1H-NMR technique to monitor the effect
of the inclusion of soy in the diet (Solanky et al., 2003). Urine
samples have also been used to investigate responses to ingestion
of chamomile tea, or other foods such as coffee, wine, and tea, evi-
dencing that hippurate and glycine are important discriminatory
metabolites (Ito et al., 2005; Wang et al., 2005).
The ability to predict the occurrence of exercise-induced
ischemia in patients with suspected cardiovascular disease was
investigated by 1H-NMR blood analysis. Barba et al. (2008)
demonstrated that lactate, glucose, lipids, and long-CFAs are
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the main metabolites involved. Xanthine and ascorbate were
proposed as possible markers of plaque formation in an
artherosclerotic mouse model (Leo and Darrow, 2009) and
lipoprotein subclasses can now be analyzed by a commercial
1H-NMR -based protocol (Jeyarajah et al., 2006; Ala-Korpela,
2007).
Even if the information provided using 1H-NMR is highly
valuable, it is still limited due to the low resolution and sensitivity
which enables the annotation and quantification of only a limited
number of low molecular weight molecules (Jansson et al., 2009).
GC-MS-basedmetabolomics requires a high-throughput tech-
nology to handle a large volume of samples and accurate peak
identification through the standard retention times and mass
spectra. GC-MS has been widely used for metabolomics and
can provide efficient and reproducible analysis (Zhang et al.,
2011). In fact, it is also possible to obtain, simultaneously pro-
files of several hundred compounds including organic acids,
most amino acids, sugars, sugar alcohols, aromatic amines, and
FAs. GC-MS Solid-Phase Microextraction (SPME) based anal-
ysis can be considered as a very effective method for rapidly
qualitatively and quantitatively analyze faecal samples most of
which have not been previously reported (Garner et al., 2007).
In particular, GC-MS/SPME represents a novel method to study
metabolic profiles of biological samples. This approach has been
used to compare neonates and adult feces (De Lacy Costello
et al., 2008) and to identify volatile markers of GI diseases
(Garner et al., 2007). The main metabolites identified by GC-
MS/SPME belong to sulphur compounds, nitrogen compounds
such as pyridine, and its derivatives, pyrazines, indoles, alde-
hydes, ketones, esters, alcohols, phenols, organic acids, hydro-
carbons, and stress molecules such as furans and furanones.
Vitali et al. (2010) investigated the impact of a synbiotic food
on a human gut microbial ecology and metabolic profiles by
using this technique. While no significant changes in the struc-
ture of the gut microbiota of healthy subjects was observed,
the synbiotic food intake generated significant changes in some
gut metabolic activities. The Canonical discriminant Analysis
of Principal coordinates (CAP) of the fecal metabolic profiles
showed a separation of subjects depending on synbiotic food
intake. Recently, the GC-MS/SPME analysis of human feces has
been also proposed as a tool to evaluate the in vitro effect of
prebiotics and probiotics on the human microbiota (Vitali et al.,
2012).
Zheng et al. (2011) applied an untargeted GC-MS-based
metabonomics approach to profile bacterial metabolites in nor-
mal Wistar rats administrated with a broad spectrum β-lactam
antibiotic imipenem/cilastatin sodium. In depth, metabolic phe-
notyping allowed the identification of 202 urinary and 223
fecal metabolites, many of which not previously reported (e.g.,
oligopeptides and carbohydrates), significantly related to a func-
tional metagenome (Zheng et al., 2011). Moreover, Maccaferri
et al. (2010) investigated the impact of rifaximin administra-
tion on microbial metabolic profiles by using GC-MS/SPME.
At the same time this technique was also used in combination
with the 1H-NMR technique to investigate the metabolome of 19
celiac disease children under gluten-free diet (treated celiac dis-
ease, T-CD) and 15 healthy children (HC). The metabolome of
T-CD and HC children was studied using fecal and urine sam-
ples. With this approach the authors showed that the levels of
volatile organic compounds and free amino acids in fecal and/or
urine samples were markedly due to affected by CD (Di Cagno
et al., 2011). Francavilla et al. (2012) used GC-MS/SPME to study
the influence of lactose on the composition of the gut micro-
biota and metabolome of infants presenting with cow’s milk
allergy.
Moreover, MS and HPLC techniques are commonly used for
compounds’ characterization at structural level. In the field of
metabolomics, both MS and HPLC are often combined to char-
acterize unknown endogenous or exogenous from a complex
biological matrix. LC is probably the most versatile separation
method, as it allows separation of compounds of a wide range
of polarity with little effort in sample preparation (compared to
GC-MS) (Moco et al., 2007). Indeed, large-scale metabolomic
technologies based on LC-MS are increasingly gaining attention
for their use in human disease diagnosis (Courant et al., 2009).
In addition, GC-MS and LC-MS have been integrated to pro-
vide the comprehensive metabolic signature of the malnutrition
in rat model and to discover differential metabolites (Wu et al.,
2010).
Recently, the combination of UPLC with MS has covered
a large number of polar metabolites enlarging the number of
detectable analytes.
Like NMR, vibrational spectroscopies such as RAMAN and
FTIR are comparable in sensibility, but the latter allows high-
throughput screening and biological samples classification, and
equally fits the “omics philosophy” of providing unbiased, whole-
system measurements (Kell, 2004). In particular, the use of
FTIR spectroscopy to monitor biochemical changes in living cells
has gained considerable importance in the last decade. In fact,
this technique presents the possibility to simultaneously iden-
tify various cellular biochemical targets, both in vivo and in vitro
conditions, exploiting the differential infrared radiation absorp-
tion of each metabolites at specific wave number (Salman et al.,
2004). Molecules and systems of biological relevance that can
be detected by FTIR spectroscopy including molecules such as
lipids and fatty acids, proteins, peptides, carbohydrates, nucleic
acids as well as biomembranes, animal tissues, microbial cells
plants, and clinical samples (Dole et al., 2011). This technique
has been employed to characterize isolated biological molecules,
particularly proteins, and lipids. However, more recently it has
been used, with the aid of sophisticated sampling techniques
such as infrared imaging, in the diagnosis of many diseases
such as cervical cancer, Parkinson’s disease, Alzheimer’s disease,
kidney stone and arthritis (Dole et al., 2011). In fact, FTIR spec-
troscopy can effectively provide chemical variation information
about the structure and the composition of biological material at
molecular level. Li et al. (2012) reported that colitis and colon
cancer can be successfully identified and discern by analyzing
colon biopsies through FTIR spectroscopy and chemometrics.
Also, Argov et al. (2004) used FTIR microspectroscopy to dis-
tinguish IBDs from colitis-associated colon carcinomas, when
pathological symptoms are similar. In particular, the study of dif-
ferences in specific regions of the infrared spectra allowed the
identification of the discriminating molecules, e.g., the phosphate
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content and RNA/DNA ratio, as different in IBD, cancer, or
normal tissues. Furthermore, FTIR spectroscopy has also been
used by Bright et al. (2011) to determine the efficacy of plasma
homocysteine levels on vitamin supplementation in diet in hyper-
lipidemic patients. Human plasma samples from healthy and
chronic lymphocytic leukemia patients have been analyzed by
FTIR spectroscopy by Erukhimovitch et al. (2006), leading to
identify of specific spectral peaks as associated with biomarkers
of the disease. Cluster analysis of the selected spectra provided
excellent classifications correlated completely with clinical data,
showing, not with standing. Although these results are prelim-
inary, but promising, rapid, effective, and economic technique
which can assist in the disease diagnosis.
However, the technique selection depends on the kind of
followed approach: (1) HPLC, GC-MS, LC-MS are employed
in metabolite target analysis, e.g., determination and quan-
tification of known metabolites or products of particular
biochemical pathways; (2) HPLC-MS, CE-MS, LC-NMR, are
used in metabolite profiling studies, e.g., larger, defined set
of compounds survey and lipid analysis; (3) NMR, Direct
Infusion electrospray Ionization-MS (DIMS), Laser Desorption
Ionization-MS (LDI-MS), Matrix Suppressed LDI-MS (MSLDI-
MS), FTIR, and Raman spectroscopy are used in metabolic
fingerprinting, e.g., generation and comparison of sample
metabolic profiles to identify differences (Shulaev, 2006)
(Figure 2).
Furthermore, the chromatography-MS systems are consid-
ered the most favorable for the detection of large numbers
of metabolites in metabolomics coupling the chromatographic
metabolite separation with the sensitivity of MS detection.
GC-Time of Flight (TOF)-MS, two dimensional GC coupled to
TOFMS (GCxGC-TOF-MS), HPLC-MS, the analytically superior
UPLC-MS and CE-MS have all been employed in mammalian
metabolomic studies, either in a metabolic profiling or targeted
analysis approach (Dunn et al., 2008). The GC-MS or GC-
MS/SPME have been widely used in metabolomic and metabo-
nomic studies, especially the second approach is useful because
it does not require a difficult or strongly pre-analytical work
flow. Garner et al. (2009) demonstrated the possibility to dis-
criminate with GC-MS/SPME between the volatile organic com-
pounds profile in fecal samples from preterm infants developing
necrotizing enterocolitis (NEC) compared with non-NEC con-
trols. Recent studies have suggested that the gut microbiota is
involved in numerous important biochemical functions for the
host, in healthy and pathological conditions (Del Chierico et al.,
2012).
The extraction of valuable conclusions from the analysis of
metabolomic data is important to perform the analytical mea-
surements; in fact, there is a variety of methods that allow the
instrument raw data transformation analyzed by the use of differ-
ent software which provide a list of metabolites. Some parameters,
such as biological variation present among individuals, sampling,
sample preparation, and analytical measurement, influence the
reproducibility of results, and these should be monitored as much
as possible by measuring replicates, both analytical and biologi-
cal. In principle, biological variance should surpass all analytical
variance (Moco et al., 2007). Retention-time shifts are common
in GC and more severely, LC, but only occasionally in NMR
and FTIR spectra. In NMR spectra, non-reproducibility seems
to be strictly related to sample preparation and hardly ever due
to instrumental incoherence. Nevertheless, even in strictly con-
trolled conditions, signal shifts may persist. For this reason, the
use of signal-alignment software [e.g., MetAlign (De Vos et al.,
2007), XCMS (Smith et al., 2006), andMZmine (Katajamaa et al.,
2006)] has become a routine procedure for comparing chro-
matograms or spectra in MS applications, while HiRes is suitable
in NMR (Zhao et al., 2006), transforming raw data into workable
informative datasets.
FIGURE 2 | Different approaches and respective techniques: pitfalls and strengths. The employed technique depends on the followed approach: targeted
analysis, metabolite profiling, and metabolic fingerprinting.
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HOW TO MANAGE AND INTEGRATE ALL DATASETS?
It is difficult to correlate specific markers with risk for disease,
nutritional state or diet choices. Instead, by examining the sys-
tem as a whole and exploring multiple pathways simultaneously,
a greater indication of a healthy or pathological state can be
acquired. Hence, this new approach, characterized by a high-
throughput determination of hundreds of metabolites, leads to
a torrent of data, in fact, over the years, there have been constant
upgrade in the hardware and the software of these technologies to
meet the demands for robustness, practicality, applicability, and
efficiency of the analyses. Therefore, powerful analytical strate-
gies in combination with advanced multivariate statistical tools
are required to have a look at this new “black box” and to
extract maximum relevant information and knowledge about the
complex biological system (Bictash et al., 2010).
The use of single or combined analytical techniques or differ-
ent kind of samples inevitably leads to face the big problem of
how to manage and represent the thousands of data collected.
One of the expectations of the system biologist is that these
datasets can be integrated to give a holistic picture of the state of
the system, e.g., development, ageing, health, or disease, which
provides insights enable a more biology fundamental under-
standing via unveiling network connections at molecular level
(Richards et al., 2010).
Appropriate experimental design, sample numbers and sta-
tistical analyses are required to ensure generation of accurate
and valid hypotheses and biological conclusions (Tseng and
Wong, 2005). Powerful multivariate analyses, either supervised
or unsupervised, are required to interrogate the data and define
structure-related to biological system similarities or differences
(Thalamuthu et al., 2006).
The first step for simplification of all data, but not in an arbi-
trary way, could be the use of Heat maps, where the relative
intensity value of one peak is replaced by a small colored block
(Zhou et al., 2011). Initially, it has been developed for microarray
studies, but it is already used in some metabolomic works (Spitale
et al., 2012). Rajaram and Oono (2010) proposed a new analysis,
the so-called NeatMap as an alternative to the traditional Heat
map, this offers a variety of novel plots (in 2 and 3 dimensions) to
be used in conjunction with principal component analysis (PCA)
and multi-dimensional scaling (MDS). Although, the NeatMap
has been used so far only in genomics, it could be exploited in
metabolomics as well. The second step could be the use of mul-
tivariate statistical analysis methods that can interpret different
datasets. According to Richards et al. (2010) there are three pos-
sible integration strategies: (1) inter-omic, or the integration of
data obtained from different -omic platforms (metabonomics,
genomics, proteomics, and transcriptomics); (2) inter-platform,
or the integration of data from different spectroscopic platforms
(NMR, GC-MS, LC-MS etc.,); (3) inter-samples, or the integra-
tion of data obtained from different human samples (plasma,
urine, tissue, and faeces) (Figure 3).
The most diffused multivariate methods are the PCA and the
Partial Least Squares (PLS) (Holmes et al., 2011). In particular,
PCA is widely used for multivariate of NMR or GC-MS analysis
profiling data, it is based on modeling the natural variance within
a dataset, which held to identify the underlying metabolite vari-
ables that contribute to that variance (Biais et al., 2009). PLS and
FIGURE 3 | Schematic representation of statistical data integration methods in the area of inter-omic, inter-platform, and inter-sample integration.
The management of different dataset derived from the metabolomic approaches are integrated by the most diffuse multivariate methods.
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its derivative orthogonal PLS (OPLS) have been also used for
NMR profiling data. In comparison with PLS, OPLS produces
models which are more clear and therefore easier to interpret,
leading to a better class-resolution in a discriminant problem
(Stella et al., 2006). However, when PCA and PLS are used for
the interpretation of several different, but potentially connected,
datasets (called “blocks”), the loading plots are usually complex
due to the co-variation in the spectrum, and therefore difficult to
correlate to the corresponding score plot (Janné et al., 2001). For
this reason a multiblock technique must be used. The common
trend of the different blocks is revealed in the “super scores” plot,
where the distribution of the samples of each individual block are
shown in their respective “block scores,” and similarly to classi-
cal PCA, the contribution of variables to the trend shown in the
blocks scores plot is shown in their “block loadings” plot (Biais
et al., 2009).
The hierarchical multiblock segmentation techniques (HPCA,
HPLS) are based on new variables created from the original data
by blocking the spectra into sub-spectra, and then projecting
the sub-spectra by PCA. These new variables are then used in
the coming PCA or PLS calculations, reducing the random and
non-wanted signals from e.g., light scatter, but still conserving
all systematic information in the signals. This technique gives
the greatest advantage of easier interpretation of the correlation
between scores and loadings (Janné et al., 2001).
Another kind of multiblock PCA used is the Consensus PCA
(CPCA), it can focus the data analysis on the relation between the
specified metabolites and the remaining metabolites, searches for
trends that explain as much as of the variation as possible (Biais
et al., 2009). CPCA was introduced as a method for compar-
ing several blocks of descriptor variables measured on the same
objects and its difference whit respect to HPCA is in the data
normalization (Westerhuis et al., 1998).
Also, the multivariate analysis, such as the Canonical
Correlation Analysis (CCA) and the regularized CCA are widely
used to integrate datasets obtained fromdifferent source materials
(Yamamoto et al., 2008). However, when the “normal” variance
is greater than that explained by the process of interest, the
most sophisticated genetic (Johnson et al., 2001) or neural net-
work (Ahmed et al., 2009) based algorithms, may identify the
underlying variables of significance which are not associated with
the greatest variance (the “normal” condition). In these cases,
such algorithm-based models should not be overfit (Biais et al.,
2009).
As the holistic approach to biological systems comprehension
continually evolves, the techniques used to analyze and integrate
the datasets must be steadily updated to manage the problems
occurring during techniques application. Hence, system biolo-
gists have a key role in the inter-pretation of the meaning of the
results obtained by the datasets management.
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